Strumento inattivo

Altre lingue Caribbean International Holdings Inc Other OTC

Azioni

US1418201000

Prezzo di chiusura Other OTC Altri mercati azionari
- ^USD	-

2023

NovaBay commercializzerà l'allotrapianto di tessuto amniotico di BioStem

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments	14:15
BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM)	14:02
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM)	10:34
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers	10/07
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study	26/06
UPDATE -- PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion	17/06
BioStem Technologies to Sponsor MRO Better Half Dash	29/05
4 Stocks to Watch in the Booming Regenerative Medicine Market	20/05
Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M	14/05
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million	14/05
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024	07/05
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent	06/05
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts	30/04
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase	25/04
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange	24/04
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference	02/04
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase	01/04
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024	21/03
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market	26/02
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies	30/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Caribbean International Holdings Inc Other OTC

Azioni

US1418201000

Altre lingue

Filtri